Sangamo Biosciences's total assets for Q1 2025 were $86.17M, a decrease of -15.22% from the previous quarter. SGMO total liabilities were $81.26M for the fiscal quarter, a 3.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.